219 related articles for article (PubMed ID: 18514501)
1. Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: a randomised controlled trial.
Sinn N; Bryan J; Wilson C
Prostaglandins Leukot Essent Fatty Acids; 2008; 78(4-5):311-26. PubMed ID: 18514501
[TBL] [Abstract][Full Text] [Related]
2. Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD.
Sinn N; Bryan J
J Dev Behav Pediatr; 2007 Apr; 28(2):82-91. PubMed ID: 17435458
[TBL] [Abstract][Full Text] [Related]
3. Physical fatty acid deficiency signs in children with ADHD symptoms.
Sinn N
Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):109-15. PubMed ID: 17825546
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
Voigt RG; Llorente AM; Jensen CL; Fraley JK; Berretta MC; Heird WC
J Pediatr; 2001 Aug; 139(2):189-96. PubMed ID: 11487742
[TBL] [Abstract][Full Text] [Related]
5. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
[TBL] [Abstract][Full Text] [Related]
6. Polyunsaturated fatty acids, cognition and literacy in children with ADHD with and without learning difficulties.
Milte CM; Sinn N; Buckley JD; Coates AM; Young RM; Howe PR
J Child Health Care; 2011 Dec; 15(4):299-311. PubMed ID: 21828168
[TBL] [Abstract][Full Text] [Related]
7. Effects of iron supplementation on attention deficit hyperactivity disorder in children.
Konofal E; Lecendreux M; Deron J; Marchand M; Cortese S; Zaïm M; Mouren MC; Arnulf I
Pediatr Neurol; 2008 Jan; 38(1):20-6. PubMed ID: 18054688
[TBL] [Abstract][Full Text] [Related]
8. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial.
Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
Nutrition; 2012 Jun; 28(6):670-7. PubMed ID: 22541055
[TBL] [Abstract][Full Text] [Related]
9. The role of fatty acids in the treatment of ADHD.
Chalon S
Neuropharmacology; 2009 Dec; 57(7-8):636-9. PubMed ID: 19715711
[TBL] [Abstract][Full Text] [Related]
10. Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
Pietrzak RH; Mollica CM; Maruff P; Snyder PJ
Neurosci Biobehav Rev; 2006; 30(8):1225-45. PubMed ID: 17161238
[TBL] [Abstract][Full Text] [Related]
11. Which polyunsaturated fatty acids are active in children with attention-deficit hyperactivity disorder receiving PUFA supplementation? A fatty acid validated meta-regression analysis of randomized controlled trials.
Puri BK; Martins JG
Prostaglandins Leukot Essent Fatty Acids; 2014 May; 90(5):179-89. PubMed ID: 24560325
[TBL] [Abstract][Full Text] [Related]
12. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder.
Richardson AJ; Montgomery P
Pediatrics; 2005 May; 115(5):1360-6. PubMed ID: 15867048
[TBL] [Abstract][Full Text] [Related]
13. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents.
Johnson M; Ostlund S; Fransson G; Kadesjö B; Gillberg C
J Atten Disord; 2009 Mar; 12(5):394-401. PubMed ID: 18448859
[TBL] [Abstract][Full Text] [Related]
14. The impact of polyunsaturated fatty acids in reducing child attention deficit and hyperactivity disorders.
Transler C; Eilander A; Mitchell S; van de Meer N
J Atten Disord; 2010 Nov; 14(3):232-46. PubMed ID: 20424008
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylserine enriched with polyunsaturated n-3 fatty acid supplementation for attention-deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo-controlled trial.
Rheims S; Herbillon V; Gaillard S; Mercier C; Villeuve N; Villéga F; Cances C; Castelnau P; Napuri S; de Saint-Martin A; Auvin S; Nguyen The Tich S; Berquin P; de Bellecize J; Milh M; Roy P; Arzimanoglou A; Bodennec J; Bezin L; Kassai B;
Epilepsia Open; 2024 Apr; 9(2):582-591. PubMed ID: 38173190
[TBL] [Abstract][Full Text] [Related]
16. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial.
Widenhorn-Müller K; Schwanda S; Scholz E; Spitzer M; Bode H
Prostaglandins Leukot Essent Fatty Acids; 2014; 91(1-2):49-60. PubMed ID: 24958525
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN12610000978066.
Kean JD; Camfield D; Sarris J; Kras M; Silberstein R; Scholey A; Stough C
Nutr J; 2013 Jul; 12():100. PubMed ID: 23866813
[TBL] [Abstract][Full Text] [Related]
18. Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD).
Joshi K; Lad S; Kale M; Patwardhan B; Mahadik SP; Patni B; Chaudhary A; Bhave S; Pandit A
Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):17-21. PubMed ID: 16314082
[TBL] [Abstract][Full Text] [Related]
19. Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial.
Kean JD; Sarris J; Scholey A; Silberstein R; Downey LA; Stough C
Psychopharmacology (Berl); 2017 Feb; 234(3):403-420. PubMed ID: 27921139
[TBL] [Abstract][Full Text] [Related]
20. Childrens' learning and behaviour and the association with cheek cell polyunsaturated fatty acid levels.
Kirby A; Woodward A; Jackson S; Wang Y; Crawford MA
Res Dev Disabil; 2010; 31(3):731-42. PubMed ID: 20172688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
